Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Sep 15, 2014 at 9:55 AM EDT

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

NPS Pharmaceuticals traded lower on what sounded like good news. The problem is that headlines often do not reveal the…

Jon C. Ogg | Sep 12, 2014 at 9:25 AM EDT

Deep Discount for Health Care REIT Secondary Offering

Health Care REIT has joined the waves of companies looking to raise capital after strong share price gains.

Chris Lange | Sep 11, 2014 at 9:20 AM EDT

Short Sellers Remain Vigilant Against Biotechs

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest…

Chris Lange | Sep 10, 2014 at 5:09 PM EDT

Virobay Files For Initial Public Offering

ThinkstockVirobay, Inc. has filed with the Securities and Exchange Commission for an initial public offering. There were no terms given…

Chris Lange | Sep 10, 2014 at 3:02 PM EDT

Does New Data Make or Break NPS Pharmaceuticals?

ThinkstockNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is up huge in regular trading on Wednesday, due to positive preliminary results of a clinical…

Chris Lange | Sep 10, 2014 at 9:40 AM EDT

IPO Filing: Xenon Pharmaceuticals

Xenon Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Lee Jackson | Sep 10, 2014 at 9:30 AM EDT

5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act

While not flashy or super high-profile, these health care companies are expected to deliver solid earnings growth for the foreseeable…

Chris Lange | Sep 9, 2014 at 9:45 AM EDT

IPO Filing: PRA Health Sciences — from KKR

PRA Health Sciences has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Lee Jackson | Sep 9, 2014 at 8:30 AM EDT

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy…

Lee Jackson | Sep 8, 2014 at 9:10 AM EDT

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

SunTrust Robinson Humphrey opens up coverage of the biotech sector with four top biotech stocks to buy and one Neutral-rated…

Chris Lange | Sep 5, 2014 at 3:05 PM EDT

Keryx Finds Out That Not All FDA Approvals Are Great Wins

ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) announced on Friday that it had received approval from the FDA on its most recent…

Chris Lange | Sep 5, 2014 at 10:35 AM EDT

Huntington’s Disease Orphan Drug Designation Could Rescue Prana

Prana Biotechnology saw its shares surge on Friday, on the heels of the FDA granting an orphan drug designation to…

Jon C. Ogg | Sep 4, 2014 at 4:45 PM EDT

What This Skin Cancer Drug Approval Really Means to Merck

Merck & Co. has received approval from the FDA to bring its new drug Keytruda to market.

Jon C. Ogg | Sep 3, 2014 at 5:58 PM EDT

Alarming Health Care Spending Forecasts as Percentage of GDP

ThinkstockThe Centers for Medicare and Medicaid Services (CMS) has projected that the current number of uninsured people is expected to…

Jon C. Ogg | Sep 3, 2014 at 2:10 PM EDT

Is Infinity Fully Valued Now, or Is More Upside Left?

Infinity Pharmaceuticals will partner with Abbvie to further develop and commercialize IPI-145, also known as Duvelisib.

1 … 281 282 283 284 285 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

Deep Discount for Health Care REIT Secondary Offering

Short Sellers Remain Vigilant Against Biotechs

Virobay Files For Initial Public Offering

Does New Data Make or Break NPS Pharmaceuticals?

IPO Filing: Xenon Pharmaceuticals

5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act

IPO Filing: PRA Health Sciences — from KKR

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

Keryx Finds Out That Not All FDA Approvals Are Great Wins

Huntington’s Disease Orphan Drug Designation Could Rescue Prana

What This Skin Cancer Drug Approval Really Means to Merck

Alarming Health Care Spending Forecasts as Percentage of GDP

Is Infinity Fully Valued Now, or Is More Upside Left?

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

The Unusual BDC Thriving While Private Credit Fears Spread Across the Sector

ARKX Faces a Concentration Crisis as SpaceX IPO Looms Over Space ETF Holdings

Fidelity Built 3 ETFs That Quietly Outpace Their Vanguard Rivals, and Cost Almost Nothing

American Families' Net Worth Jumped 37% Since 2019, But Their Paychecks Barely Moved

"Sitting on a Tax Time Bomb": Jim Saulnier's Warning to Retiree With $2 Million

Apple Hits Near-Record High, While Chip Stocks Face Pullback Risk After Massive Rally

Etsy, Amazon, eBay, and Shopify in April: Why E-Commerce Stocks Diverged So Dramatically

Health and Healthcare Articles

All Health and Healthcare Articles

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

Deep Discount for Health Care REIT Secondary Offering

Short Sellers Remain Vigilant Against Biotechs

Virobay Files For Initial Public Offering

Does New Data Make or Break NPS Pharmaceuticals?

IPO Filing: Xenon Pharmaceuticals

5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act

IPO Filing: PRA Health Sciences — from KKR

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

Keryx Finds Out That Not All FDA Approvals Are Great Wins

Huntington’s Disease Orphan Drug Designation Could Rescue Prana

What This Skin Cancer Drug Approval Really Means to Merck

Alarming Health Care Spending Forecasts as Percentage of GDP

Is Infinity Fully Valued Now, or Is More Upside Left?

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

The Unusual BDC Thriving While Private Credit Fears Spread Across the Sector

ARKX Faces a Concentration Crisis as SpaceX IPO Looms Over Space ETF Holdings

Fidelity Built 3 ETFs That Quietly Outpace Their Vanguard Rivals, and Cost Almost Nothing

Featured Reads

American Families' Net Worth Jumped 37% Since 2019, But Their Paychecks Barely Moved

"Sitting on a Tax Time Bomb": Jim Saulnier's Warning to Retiree With $2 Million